New Experimental Facts on the Influence of Secondary Immunodeficiency on the Morphology and Biological Activity of Colorectal Tumor


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Colorectal tumors were studied 5 months after carcinogen injection to outbred albino rats with secondary immunodeficiency by common histological and immunobiochemical methods with the use of monoclonal and polyclonal antibodies to Ki-67, Bcl-2, p53, and VEGF. Injection of carcinogen to intact animals led to the formation of adenocarcinomas with high and moderate cell differentiation in the colon, while injection of carcinogen to animals with immunodeficiency was associated with a 1.5-fold higher incidence of GRADE 2 and GRADE 3 adenocarcinomas with more aggressive morphological phenotype and appearance of distant metastases.

About the authors

G. Yu. Struchko

Department of Normal and Topographic Anatomy with Operative Surgery, I. N. Ulyanov Chuvash State University

Author for correspondence.
Email: glebstr@mail.ru
Russian Federation, Cheboksary, Chuvash Republic

L. M. Merkulova

Department of Normal and Topographic Anatomy with Operative Surgery, I. N. Ulyanov Chuvash State University

Email: glebstr@mail.ru
Russian Federation, Cheboksary, Chuvash Republic

E. V. Moskvichev

Department of Normal and Topographic Anatomy with Operative Surgery, I. N. Ulyanov Chuvash State University

Email: glebstr@mail.ru
Russian Federation, Cheboksary, Chuvash Republic

O. Yu. Kostrova

Department of Normal and Topographic Anatomy with Operative Surgery, I. N. Ulyanov Chuvash State University

Email: glebstr@mail.ru
Russian Federation, Cheboksary, Chuvash Republic

M. N. Mikhailova

Department of Normal and Topographic Anatomy with Operative Surgery, I. N. Ulyanov Chuvash State University

Email: glebstr@mail.ru
Russian Federation, Cheboksary, Chuvash Republic


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies